Mosaic ImmunoEngineering (CPMV) Net Cash Flow (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Net Cash Flow of -$3550.0 for Q1 2026, up 87.8% year-over-year from -$1890.3 in Q1 2025, and up 87.38% quarter-over-quarter from -$28139.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Net Cash Flow (2010 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$3550.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 87.8% year-over-year to -$3550.0; the TTM figure through Mar 2026 stood at -$85858.0 (down 151.72% YoY), while the FY2025 annual figure was -$111397.0, down 170.65% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$3550.0, up from -$28139.0 in the prior quarter.
- The five-year high for Net Cash Flow was $237193.0 in Q2 2023, with the low at -$172061.0 in Q2 2022.
- The 5-year median for Net Cash Flow is -$29089.0 (2025), against an average of -$16533.5.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow soared 237.85% in 2023, then slumped 1190.01% in 2025.
- Mosaic ImmunoEngineering's Net Cash Flow stood at -$163492.0 in 2022, then surged by 40.84% to -$96720.0 in 2023, then jumped by 212.99% to $109283.0 in 2024, then slumped by 125.75% to -$28139.0 in 2025, then surged by 87.38% to -$3550.0 in 2026.
- Business Quant data shows CPMV's Net Cash Flow at -$3550.0 in Q1 2026, -$28139.0 in Q4 2025, and -$21822.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 225.59 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | -3,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,550.00 |
| Mar 31, 2026 | -3,550.00 |
| Dec 31, 2025 | -28,139.00 |
| Dec 31, 2025 | -28,139.00 |
| Sep 30, 2025 | -21,822.00 |
| Sep 30, 2025 | -21,822.00 |
| Jun 30, 2025 | -32,347.00 |
| Jun 30, 2025 | -32,347.00 |
| Mar 31, 2025 | -29,089.00 |
| Mar 31, 2025 | -29,089.00 |
| Dec 31, 2024 | 109,283.00 |
| Dec 31, 2024 | 109,283.00 |
| Sep 30, 2024 | 2,002.00 |
| Sep 30, 2024 | 2,002.00 |
| Jun 30, 2024 | -116,305.00 |
| Jun 30, 2024 | -116,305.00 |
| Mar 31, 2024 | -91,139.00 |
| Mar 31, 2024 | -91,139.00 |
| Dec 31, 2023 | -96,720.00 |
| Dec 31, 2023 | -96,720.00 |